Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: Positive effect on overall and progression-free survival

Journal of Clinical Oncology

Volumn 21, Issue 4, 2003, Pages 631-637

  Lin, Jin Ching ^a   Jan, Jian Sheng ^a   Hsu, Chen Yi ^a   Liang, Wen Miin ^a   Jiang, Rong San ^a   Wang, Wen Yi ^a  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL; ANTINEOPLASTIC AGENT;

ADVANCED CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER SURVIVAL; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; KAPLAN MEIER METHOD; LEUKOPENIA; LOG RANK TEST; MULTIPLE CANCER; MULTIPLE CYCLE TREATMENT; NASOPHARYNX CARCINOMA; PATIENT COMPLIANCE; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VOMITING; ADULT; AGED; CHEMICALLY INDUCED DISORDER; FEMALE; MALE; MIDDLE AGED; NASOPHARYNX TUMOR; PATHOLOGY; SURVIVAL RATE; TREATMENT FAILURE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; FEMALE; FLUOROURACIL; HUMANS; LEUKOPENIA; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; SURVIVAL RATE; TREATMENT FAILURE;

EID: 0037441720     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2003.06.158     Document Type: Article

References (53)

1. Altun M, Fandi A, Dupuis O, et al: Undifferentiated nasopharyngeal cancer (UCNT): Current diagnostic and therapeutic aspects. Int J Radiat Oncol Biol Phys 32:859-877, 1995
2. Marks JE, Philips JL, Menck HR: The national cancer data base report on the relationship of race and national origin to the histology of nasopharyngeal carcinoma. Cancer 83:582-588, 1998
3. Jiong L, Berrino F, Coebergh JWW, and the EUROCARE Working Group: Variation in survival for adults with nasopharyngeal cancer in Europe, 1978-1989. Eur J Cancer 34:2162-2166, 1998
4. Hsu MM, Tu SM: Nasopharyngeal carcinoma in Taiwan: Clinical manifestations and results of therapy. Cancer 52:362-368, 1983
5. Lee AWM, Poon YF, Foo W, et al: Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: Overall survival and patterns of failure. Int J Radiat Oncol Biol Phys 23:261-270, 1992
6. Zhang EP, Lian PG, Cai KL, et al: Radiation therapy of nasopharyngeal carcinoma: Prognostic factors based on a 10-year follow-up of 1302 patients. Int J Radiat Oncol Biol Phys 16:301-305, 1989
7. Chen WZ, Zhou DL, Luo KS: Long-term observation after radiotherapy for nasopharyngeal carcinoma (NPC). Int J Radiat Oncol Biol Phys 16:311-314, 1989
8. Qin D, Hu Y, Yan J, et al: Analysis of 1379 patients with nasopharyngeal carcinoma treated by radiation. Cancer 61:1117-1124, 1988
9. Sanguineti G, Geara FB, Garden AS, et al: Carcinoma of the nasopharynx treated by radiotherapy alone: Determinants of local and regional control. Int J Radiat Oncol Biol Phys 37:985-996, 1997
10. Boussen H, Cvitkovic E, Wendung JL, et al: Chemotherapy of metastatic. and/or recurrent undifferentiated nasopharyngeal carcinoma with cisplatin, bleomycin, and fluorouracil. J Clin Oncol 9:1675-1681, 1991
11. Azli N, Fandi A, Bachouchi M, et al: Final report of a phase II study of chemotherapy with bleomycin, epirubicin, and cisplatin for locally advanced and metastatic/recurrent undifferentiated carcinoma of the nasopharyngeal type. Cancer J Sci Am 1:222-229, 1995
12. Dimery IW, Peters LJ, Goepfert H, et al: Effectiveness of combined induction chemotherapy and radiotherapy in advanced nasopharyngeal carcinoma. J Clin Oncol 11:1919-1928, 1993
13. Hasbini A, Mahjoubi R, Fandi A, et al: Phase II trial combining mitomycin with 5-fluorouracil, epirubicin, and cisplatin in recurrent and metastatic undifferentiated carcinoma of nasopharyngeal type. Ann Oncol 10:421-425, 1999
14. Taamma A, Fandi A, Azli N, et al: Phase II trial of chemotherapy with 5-fluorouracil, bleomycin, epirubicin, and cisplatin for patients with locally advanced, metastatic, or recurrent undifferentiated carcinoma of the nasopharyngeal type. Cancer 86:1101-1108, 1999
15. Hong RL, Ting LL, Ko JY, et al: Induction chemotherapy with mitomycin, epirubicin, cisplatin, fluorouracil, and leucovorin followed by radiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma. J Clin Oncol 19:4305-4313, 2001
16. Lin JC, Chen KY, Jan JS, et al: Partially hyperfractionated accelerated radiotherapy and concurrent chemotherapy for advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 36:1127-1136, 1996
17. Lin JC, Jan JS, Hsu CY: Pilot study of concurrent chemotherapy and radiotherapy for stage IV nasopharyngeal cancer. Am J Clin Oncol 20:6-10, 1997
18. Al-Sarraf M, Pajak TF, Cooper JS, et al: Chemo-radiotherapy in patients with locally advanced nasopharyngeal carcinoma: A Radiation Therapy Oncology Group study. J Clin Oncol 8:1342-1351, 1990
19. Cheng SH, Jian JJM, Tsai SYC, et al: Prognostic features and treatment outcome in locoregionally advanced nasopharyngeal carcinoma following concurrent chemotherapy and radiotherapy. Int J Radiat Oncol Biol Phys 41:755-762, 1998
20. Beahrs, OH, Henson DE, Hutter RVP, et al (eds): Pharynx, in Manual for Staging of Cancer (ed 4). Philadelphia, PA, J.B. Lippincott, 1992, pp 33-38
21. Miller AB, Hoogstraten B, Staquet M, et al: Reporting results of cancer treatment. Cancer 47:207-214, 1981
22. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
23. Mantel N: Evaluation of survival data and two rank order statistics arising in its consideration. Cancer Chemother Rep 50:163-170, 1966
24. Rossi A, Molinari R, Boracchi P, et al: Adjuvant chemotherapy with vincristine, cyclophosphamide, and doxorubicin after radiotherapy in local-regional nasopharyngeal cancer: Results of a 4-year multicenter randomized study. J Clin Oncol 6:1401-1410, 1988
25. Chan ATC, Teo PML, Leung TWT, et al: A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 33:569-577, 1995
26. Cvitkovic E and the International Nasopharynx Cancer Study Group: Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV (≥. N2, M0) undifferentiated nasopharyngeal carcinoma: A positive effect on progression-free survival. Int J Radiat Oncol Biol Phys 35:463-469, 1996
27. Chua DTT, Sham JST, Choy D, et al: Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Cancer 83:2270-2283, 1998
28. Al-Sarraf M, LeBlanc M, Giri PGS, et al: Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup Study 0099. J Clin Oncol 16:1310-1317, 1998
29. Ma J, Mai HQ, Hong MH, et al: Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma. J Clin Oncol 19:1350-1357, 2001
30. Chi KH, Chang YC, Guo WY, et al: A phase III study of adjuvant chemotherapy in advanced nasopharyngeal carcinoma patients. Int J Radiat Oncol Biol Phys 52:1238-1244, 2002
31. Chan ATC, Teo PML, Ngan RK, et al: Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: Progression-free survival analysis of a phase III randomized trial. J Clin Oncol 20:2038-2044, 2002
32. Hareyama M, Sakata K, Shirato H, et al: A prospective, randomized trial comparing neoadjuvant chemotherapy with radiotherapy alone in patients with advanced nasopharyngeal carcinoma. Cancer 94:2217-2223, 2002
33. Santos JA, Gonzalez C, Cuesta P, et al: Impact of changes in the treatment of nasopharyngeal carcinoma: An experience of 30 years. Radiother Oncol 36:121-127, 1995
34. Bailet JW, Mark RJ, Abemayor E, et al: Nasopharyngeal carcinoma: Treatment results with primary radiation therapy. Laryngoscope 102:965-972, 1992
35. Perez CA, Devineni VR, Marcial-Vega V, et al: Carcinoma of the nasopharynx: Factors affecting prognosis. Int J Radiat Oncol Biol Phys 23:271-280, 1992
36. Petrovich Z, Cox JD, Middleton R, et al: Advanced carcinoma of the nasopharynx: Patterns of failure in 256 patients. Radiother Oncol 4:15-20, 1985
37. Vikram B, Mishra UB, Strong EW, et al: Patterns of failure in carcinoma of the nasopharynx: I. Failure at the primary site. Int J Radiat Oncol Biol Phys 11:1455-1459, 1985
38. Kwong D, Sham J, Choy D: The effect of loco-regional control on distant metastatic dissemination in carcinoma of the nasopharynx: An analysis of 1301 patients. Int J Radiat Oncol Biol Phys 30:1029-1036, 1994
39. Tannock IF: Combined modality treatment with radiotherapy and chemotherapy. Radiother Oncol 16:83-101, 1989
40. Vokes EE, Weichselbaum RR: Concomitant chemoradiotherapy: Rational and clinical experience in patients with solid tumors. J Clin Oncol 8:911-934, 1990
41. Cummings BJ, Keane TJ, O'Sullivan B, et al: Epidermoid anal cancer: Treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C. Int J Radiat Oncol Biol Phys 21:1115-1125, 1992
42. Stupp R, Weichselbaum RR, Vokes EE: Combined modality therapy of head and neck cancer. Semin Oncol 21:349-358, 1994
43. Herskovic A, Martz K, Al-Sarraf M, et al: Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 326:1593-1598, 1992
44. Schaake-Koning C, van den Bogaert W, Dalesio O, et al: Effects of concomitant cisplatin and radiotherapy on inoperable nonsmall cell lung cancer. N Engl J Med 326:524-530, 1992
45. Morris M, Eifel PJ, Lu J, et al: Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 340:1137-1143, 1999
46. Rose PG, Bundy BN, Watkins EB, et al: Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 340:1144-1153, 1999
47. Shipley WU, Prout GR, Einstein AB, et al: Treatment of invasive bladder cancer by cisplatin and radiation in patients unsuited for surgery. JAMA 258:931-935, 1987
48. Au E, Tan EH, Ang PT: Activity of paclitaxel by three-hour infusion in Asian patients with metastatic undifferentiated nasopharyngeal cancer. Ann Oncol 9:327-329, 1998
49. Fandi A, Taamma A, Azli N, et al: Palliative treatment with low-dose continuous infusion 5-fluorouracil in recurrent and/or metastatic undifferentiated nasopharyngeal carcinoma type. Head Neck 19:41-47, 1997
50. Choo R, Tannock I: Chemotherapy for recurrent or metastatic carcinoma of the nasopharynx. Cancer 68:2120-2124, 1991
51. Dugan M, Choy D, Ngai A, et al: Multicenter phase II trial of mitoxantrone in patients with advanced nasopharyngeal carcinoma in Southeast Asia: An Asian-Oceanian Clinical Oncology Association Group Study. J Clin Oncol 11:70-76, 1993
52. Chi KW, Chan WK, Shu CH, et al: Elimination of dose limiting toxicities of cisplatin, 5-fluorouracil, and leucovorin using a weekly 24-hour infusion schedule for the treatment of patients with nasopharyngeal carcinoma. Cancer 76:2186-2192, 1995
53. Lin JC, Jan JS, Hsu CY: Outpatient weekly chemotherapy in patients with nasopharyngeal carcinoma and distant metastasis. Cancer 83:635-640, 1998